top biopharmaceuticals for glp-1 medication Major global pharma updates in July 2026 feature massive market movements in the obesity and segments, multi-billion dollar M&A deals, and new clinical milestones in regenerative and Lilly's Oral GLP-1 Foundayo Outperforms

However, it can cause steatorrhea, resulting in fat-soluble vitamin deficiency, and can even cause liver damage

Wegovy is characterized by its stronger weight loss effects, requiring only once-weekly administration

GLP-1 therapy carries a risk of hypoglycemia (low blood sugar), particularly when used with other diabetes medications that lower blood glucose

Empower your strategic planning: Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in Glucagon-like peptide-1 agonists market

References: Related Articles: Top 10 Most Anticipated Drug Launches Of 2024

Amgen plans to advance AMG133 to Phase II clinical in early 2023